# Solifenacin Plus Tadalafil vs Solifenacin Alone for Overactive Bladder in Females

> **NCT07312955** · NA · COMPLETED · sponsor: **Ain Shams University** · enrollment: 80 (actual)

## Conditions studied

- Overactive Bladder

## Interventions

- **DRUG:** Solifenacin
- **DRUG:** Tadalafil

## Key facts

- **NCT ID:** NCT07312955
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-05-15
- **Primary completion:** 2025-11-15
- **Final completion:** 2025-11-15
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2025-12-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07312955

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07312955, "Solifenacin Plus Tadalafil vs Solifenacin Alone for Overactive Bladder in Females". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07312955. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*